Helix Research Network
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHelix, Inc
About this trial
The Helix Research Network ("HRN") is a network of academic, public, and/or private healthcare organizations that are committed to advancing medical research and improving human health through large-scale genomics research and acceleration of the integration of genomic and other omics data into clinical care.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
18 years and older
Willing and able to comply with all aspects of the protocol
Disqualifiers
History of allogenic bone marrow transplant
History of allogenic stem cell transplant
Anything that would place the individual at increased risk or preclude an individual's: 1) full compliance with study requirements; or 2) completion of the study based on the assessment from local consenting and enrolling Investigators.
Trial population
The study will recruit the general population from the surrounding areas of the HRN Member Sites. This may include patients within a health system of the Site or community members in the surrounding area of Sites.
Trial design
Design model
Ecologic or community
Time perspective
Other
Treatments tested in this trial
Exome sequencing
GeneticExome sequencing will be completed on each sample submitted.
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Establish a Research Network
Establish a research network to support the advancement of biomedical research, improve human health through genomics research, and accelerate integration of genomic and other omics data into clinical care.
Time frame
Through study completion, average 10 years2
Aggregate data
Aggregate molecular, genomic data, phenotypic and other health-related data in centralized and/or federated databases to be accessed by investigators for approved research purposes.
Time frame
Through study completion, average 10 years3
Re-Contact participants
Recontact participants for additional data collection, research participation opportunities, and return of results
Time frame
Through study completion, average 10 years4
Genetic biomarker identification
Identification and characterization of clinical, histological, molecular, and genetic biomarkers that are linked to disease, disease outcomes, or that might be used to improvise disease classification.
Time frame
Through study completion, average 10 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Helix, Inc
Lead sponsor
Medical University of South Carolina
Collaborator
HealthPartners Institute
Collaborator
Memorial Hermann Health System
Collaborator
WellSpan Health
Collaborator
St. Luke's Hospital and Health Network, Pennsylvania
Collaborator
Sanford Health
Collaborator
Renown Health
Collaborator
WakeMed Health and Hospitals
Collaborator
University of Nebraska
Collaborator
Ohio State University
Collaborator
Cone Health
Collaborator
Parkview Health
Collaborator
Rochester Regional Health
Collaborator
University Health Network, Toronto
Collaborator
Source ClinicalTrials.gov